Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas: Clinical investigative study

Journal of Neuroimaging

Volumn 20, Issue 1, 2010, Pages 3-8

  Chawla, Sanjeev ^a   Oleaga, Laura ^c   Wang, Sumei ^a   Krejza, Jaroslaw ^a   Wolf, Ronald L ^a   Woo, John H ^a   O'Rourke, Donald M ^a,b   Judy, Kevin D ^a,b   Grady, Michael S ^a,b   Melhem, Elias R ^a   Poptani, Harish ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL CLÍNIC   (Spain)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Astrocytomas; Gliomas; Myo inositol; Oligodendrogliomas; Proton magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATININE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID; PROTON;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; FLUID ATTENUATED INVERSION RECOVERY IMAGING; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BRAIN; BRAIN NEOPLASMS; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; AGED; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; PROTONS; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 74049134924     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2008.00307.x     Document Type: Article

References (33)

1. Kleihues P, Soylemezoglu F, Schauble B, et al. Histopathology, classification, and grading of gliomas. Glia 1995 15 : 211 221.
2. Chinot O. Chemotherapy for the treatment of oligodendroglial tumors. Semin Oncol 2001 28 : 13 18.
3. Law M, Oh S, Johnson G, Babb JS, et al. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery 2006 58 : 1099 1107.
4. Dean BL, Drayer BP, Bird CR, et al. Gliomas: classification with MR imaging. Radiology 1990 174 : 411 415.
5. Rijpkema M, Schuuring J, Van Der Meulen Y, et al. Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging. NMR Biomed 2003 16 : 12 18.
6. Peeling J, Sutherland G. High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992 24 : 123 136.
7. Thompson RB, Allen PS. A new multiple quantum filter design procedure for use on strongly coupled spin systems found in vivo: its application to glutamate. Magn Reson Med 1998 39 : 762 771.
8. Rothman DL, Behar KL, Hetherington HP, Shulman RG. Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo. Proc Natl Acad Sci USA 1984 81 : 6330 6334.
9. Pan JW, Mason GF, Pohost GM, et al. Spectroscopic imaging of human brain glutamate by water-suppressed J-refocused coherence transfer at 4.1 T. Magn Reson Med 1996 36 : 7 12.
10. Bauman GS, Cairncross JG. Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas. Semin Radiat Oncol 2001 11 : 170 180.
11. Fayed N, Morales H, Modrego PJ, et al. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas. Acad Radiol 2006 13 : 728 737.
12. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000 13 : 129 153.
13. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994 191 : 41 51.
14. Tugnoli V, Tosi MR, Barbarella G, et al. Magnetic resonance spectroscopy study of low grade extra and intracerebral human neoplasms. Oncol Rep 1998 5 : 1199 1203.
15. Uhm JH, Dooley NP, Villemure JG, et al. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin Exp Metastasis 1996 14 : 421 433.
16. Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000 21 : 1645 1649.
17. Majos C, Alonso J, Aguilera C, et al. Proton magnetic resonance spectroscopy ((1)H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization. Eur Radiol 2003 13 : 582 591.
18. Barba I, Moreno A, Martinez-Perez I, et al. Magnetic resonance spectroscopy of brain hemangiopericytomas: high myoinositol concentrations and discrimination from meningiomas. J Neurosurg 2001 94 : 55 60.
19. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993 15 : 289 298.
20. Paredes A, McManus M, Kwon HM, et al. Osmoregulation of Na(+)-inositol cotransporter activity and mRNA levels in brain glial cells. Am J Physiol 1992 263 : C1282 C1288.
21. Ross BD. Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed 1991 4 : 59 63.
22. Toker A, Cantley LC. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 1997 387 : 673 676.
23. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993 3 : 255 268.
24. Urenjak J, Williams SR, Gadian DG, et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993 13 : 981 989.
25. Norfray JF, Tomita T, Byrd SE, et al. Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors. AJR Am J Roentgenol 1999 173 : 119 125.
26. Podo F. Tumour phospholipid metabolism. NMR Biomed 1999 12 : 413 439.
27. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996 84 : 449 458. (Pubitemid 26062870)
28. Hagberg G, Burlina AP, Mader I, et al. In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification. Magn Reson Med 1995 34 : 242 252.
29. Prescot AP, de BFB, Wang L, et al. In vivo detection of brain glycine with echo-time-averaged (1)H magnetic resonance spectroscopy at 4.0 T. Magn Reson Med 2006 55 : 681 686.
30. Petroff OA, Spencer DD, Alger JR, et al. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 1989 39 : 1197 1202.
31. Lehnhardt FG, Bock C, Rohn G, et al. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. NMR Biomed 2005 18 : 371 382.
32. Kim H, Wild JM, Allen PS. Strategy for the spectral filtering of myo-inositol and other strongly coupled spins. Magn Reson Med 2004 51 : 263 272.
33. Brereton IM, Galloway GJ, Rose SE, et al. Localized two-dimensional shift correlated spectroscopy in humans at 2 Tesla. Magn Reson Med 1994 32 : 251 257.